Home / Early Access

Join early access.

Stride is a concept we are building toward 2030 – a powered exoskeleton designed to share the work of standing, balancing, and walking. It is not for sale, and it is not yet a cleared medical device. Join the early-access list to follow our honest progress and be among the first contacted when prototypes, trials, and pre-orders are real.

 Joining is free. There is no payment, no card, and no commitment. We will not ask for medical details here, and we will never give medical advice by email. We will send honest development updates, and reach out first when Stride is ready for the next step. Unsubscribe any time; we never sell your details.

Free · no payment · no medical advice by email · unsubscribe any time · never sold.

The road to 2030

Built in the open, milestone by milestone.

Where Stride is today and what has to be proven – including clinical validation and the regulatory pathway – before it ships. We’ll keep this honest as it changes.

2026

Concept and industrial design

Stride (MM-1) form and system language locked – FeatherFrame frame, LiftDrive joints, IntentSense control, TrueBalance stability. Renders, ergonomics, and human-centered design only; this is a concept, not a shipping device.

Complete
2027

Actuation and safety bench proving

Validating whether LiftDrive can deliver useful, safe assistance at the hip and knee within a wearable weight and power budget. Honestly the hardest open problem – torque, timing, efficiency, and the SoftStop fail-safes under active test.

In progress now
2028

Gait and balance prototypes

Supervised prototype trials to prove IntentSense responsiveness and TrueBalance stability across different bodies and gaits, in a controlled setting and alongside movement specialists. Assistance levels and comfort characterized honestly.

Planned
2029

Clinical validation and regulatory pathway

Structured studies with clinical partners and the beginning of the regulatory process that assistive and medical devices must pass. No safety or benefit claims are made final until this work supports them.

Planned
2030

Stride – targeted release

Intended availability of the MM-1 if – and only if – the assistance, safety, and validation targets hold. Everything on this site is a design goal, not a guarantee; we will publish what actually ships and what it is cleared to do.

Planned
Questions

The honest answers.

Not yet. Stride is a concept in active development, targeting 2030. It is not currently a cleared or approved medical device, and it is not for sale. Part of our roadmap is the clinical validation and regulatory process that assistive devices must pass, and we will not describe Stride as cleared for anything until that work supports it. Join the early-access list and we will tell you the moment there is a real, honest next step.
We have to be honest here, because it matters: Stride is designed to assist movement, not to cure any condition or to guarantee that anyone will walk or stand a particular way. It is a machine that shares the effort of standing, balancing, and walking. What it can do for a specific person depends on that person, and is a decision for them and their clinicians – not a promise we can make from a website. Anyone who guarantees you a miracle is not being straight with you.
That is a medical question, and it belongs with your care team. Whether a powered exoskeleton is appropriate, safe, and useful for someone depends on their body, their condition, and their goals, and should be decided with the clinicians who know them. Stride is being designed to be set up and reviewed alongside that care, never as a substitute for it.
Safety is the first thing we are designing for, and honesty about it is part of that. TrueBalance is meant to assist your stability and help ease a wobble before it becomes a stumble, and SoftStop is designed so the frame yields to you and fails gently rather than fighting you. But no wearable machine can promise you will never fall, and we will not pretend otherwise. Real safety figures will be published as testing matures.
We have not set a price, and we will not guess at one to sound impressive. Cost, and how it might work with insurance or care programs, are things we intend to address honestly closer to release. Join the early-access list and you will be among the first to see real pricing when it exists.
We are targeting 2030, and only if the assistance, safety, and validation targets hold. We are proving out LiftDrive actuation and the SoftStop safety behavior now, and we will share honest milestones as we go rather than promise a date we cannot keep.
A wheelchair is a mature, excellent tool for many people; Stride is not a replacement for it, and for some people a chair will always be the better choice. Stride is aimed at people who want assistance to stand and walk. Powered exoskeletons for mobility already exist in research and clinical settings, and we build on that real work – our focus is a lighter, more wearable, more human frame for everyday assistance, developed honestly and openly.
Nothing. Joining is completely free – no payment, no card, no obligation. We will not collect medical information there, and we will never give medical advice by email. You are opting in to honest updates and an early place in line, and you can leave at any time. We never sell your information.
Follow the build

Be first to move with it.

No hype, no spam – just honest updates on Stride as we build it, the hard parts included. Join the list and we will reach out first when there is a real next step.